Ozempic and vision loss: what the research actually shows
A small but striking study links semaglutide and tirzepatide to serious eye conditions, raising questions researchers say are worth taking seriously even if the risk remains low. Weight loss medications have reshaped how doctors approach obesity and blood sugar management. Ozempic and Zepbound, which contain semaglutide and tirzepatide respectively, have become […]
Celebrities who’ve taken Ozempic and GLP-1 weight loss drugs
Ozempic and its GLP-1 counterparts are no longer Hollywood’s best kept secret. What started as whispered speculation about sudden transformations on red carpets has turned into a growing chorus of celebrity voices speaking openly about weight loss medication. Their willingness to share is doing something quietly powerful and shifting the conversation from shame toward honesty. […]
The pros, cons, and considerations of taking ozempic or other drugs for weight loss
Ozempic has become one of the most talked about medications in recent memory, and for good reason. A growing number of people who spent years struggling with weight have finally found something that works. But behind the Ozempic hype is a more layered story, one that deserves a closer look before anyone rushes to their […]
Eating disorders in older women are rising and GLP-1 drugs are making it worse
Eating disorders affect more than 30 million people in the United States, and a growing body of research suggests that the surge in GLP-1 weight loss medications may be making things significantly worse for one of the most overlooked groups: women over 50. One in eight American adults is currently taking a GLP-1 medication, and […]
Ozempic’s New Pill Form Could Change Who Has Access
Novo Nordisk has begun selling an oral version of semaglutide in the United States under the Ozempic name, a move that extends one of the most recognized drug brands in recent memory into a format that does not require an injection. The pill became available on May 4, 2026, at more than 70,000 pharmacies nationwide, […]
GLP-1 weight loss drugs may be sparing muscle more than anyone expected
A review of 36 studies on GLP-1 medications suggests most of the weight lost comes from fat, not muscle, offering some reassurance to the millions now using these drugs. GLP-1 medications have moved from niche diabetes treatment to one of the most prescribed drug categories in the country in a remarkably […]
Ozempic breath is a real problem: here’s what causes it
GLP-1 receptor agonist medications like Ozempic and Wegovy have become some of the most talked about drugs in recent years, largely praised for their effectiveness in managing type 2 diabetes and supporting weight loss. But alongside the well known gastrointestinal complaints nausea, bloating, and constipation a lesser discussed side effect has been making its way […]
DIY peptide injections are sending people to the ER
What started as a niche interest among bodybuilders has quietly spread to suburban moms, white collar professionals and affluent antiaging enthusiasts and now doctors at high-end longevity clinics are dealing with the fallout. People are increasingly sourcing injectable peptides online, from grey market sellers, or secondhand from friends treating the practice. A peptide is a […]
New study finds 1 gene variant that boosts GLP-1 results
GLP-1 receptor agonists like semaglutide and tirzepatide have become some of the most talked about medications in modern medicine, reshaping how millions of people approach weight loss. But a sweeping new study suggests that the results people experience may have less to do with willpower or lifestyle and more to do with what is written […]
Ways GLP-1 drugs affect your sex life
Medications known as GLP-1 receptor agonists have quickly become household names, widely used for managing Type 2 diabetes and supporting weight loss. Drugs like Ozempic, Wegovy, Mounjaro, and Zepbound are often discussed in terms of shrinking waistlines. But researchers are beginning to ask a more personal question: Could these medications also be reshaping people’s sex […]